Virginia · 86409

Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in Virginia

Virginia Medicare Avg
$78.02
17% below national avg
National Medicare Avg
$93.92
All states combined
Billed Charge (VA)
$159.22
What providers submit
Est. Commercial (VA)
$171.64
National avg: $210.38
Est. Cash / Self-Pay (VA)
$102.30
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

407
Services in VA
2
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Virginia

Provider Medicare Services
Aditxt, Inc. $78.02 309
Pearsanta, Inc. $78.02 98

Virginia Pricing in Context

In Virginia, CPT code 86409 (Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)) carries an average Medicare payment of $78.02 — 17% below the national benchmark of $93.92. 2 providers across the state submitted claims for this procedure in 2023, performing 407 total services. Individual payments in VA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Virginia is $159.22, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Virginia sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Virginia lands near $171.64, with self-pay cash prices typically around $102.30. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cost in Virginia?

The average Medicare payment for Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in Virginia is $78.02, which is 17% below the national average of $93.92. Providers in VA typically bill $159.22 for this procedure.

What does Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cost with insurance in Virginia?

With commercial insurance in Virginia, Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) costs an estimated $171.64. Without insurance, the estimated cash price is $102.30. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in Virginia?

2 providers in Virginia billed Medicare for Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in 2023, performing 407 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cheaper in Virginia than the national average?

Yes — Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) costs 17% below the national average in Virginia. The state average Medicare payment is $78.02 compared to $93.92 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial